A novel multiplex assay for species-level identification of non-tuberculous mycobacteria in culture-positive respiratory specimens based on capillary electrophoresis: development and clinical validation
4 affiliations
- 1Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University
- 2Tuberculosis Laboratory, International Medical Examination Center, Fuzhou University Affiliated Provincial Hospital
- 3Department of Clinical Laboratory, Fuzhou University Affiliated Provincial Hospital
- 4Department of Health Management, Fuzhou University Affiliated Provincial Hospital
Abstract
Nontuberculous mycobacterial pulmonary disease (NTM-PD) is rising globally, driven predominantly by Mycobacterium avium complex (MAC), yet treatment is highly species-dependent. We developed a Multiplex assay targeting four clinically important non-tuberculous mycobacteria (NTM) species– M. avium , M. intracellulare , M. abscessus , and M. fortuitum –and compared it with metagenomic next-generation sequencing (mNGS), using colony-based multigene Sanger sequencing as the reference method. Among 101 specimens, 63 (62.4%) yielded polymicrobial results, of which mixed-species detection of M. avium – M. intracellulare accounted for 46 (73.0%). The Multiplex assay and mNGS showed no statistically significant difference in overall accuracy in this cohort (82.2% vs. 81.2%; raw agreement 83.2%, P = 1.000). The Multiplex assay achieved 100.0% sensitivity for all four species, with specificity of 87.8% and 87.5% for M. avium and M. intracellulare , respectively, and >98% for M. abscessus and M. fortuitum ; mNGS showed the converse pattern, with lower MAC sensitivity (88.5%, 92.2%) but higher MAC specificity (93.9%, 95.8%). Requiring only a single PCR reaction without sequencing or bioinformatic analysis, the Multiplex assay showed no statistically significant difference in diagnostic accuracy from mNGS in this culture-positive cohort, without requiring library preparation or sequencing, representing a promising candidate for further evaluation as a routine NTM species-identification tool.
Related
- Pseudomonas aeruginosa, non-tuberculous mycobacteria and other Gram-negative organisms in healthcare water and wastewater systems.
- Signal-Oriented Framework for Early Identification of Imported Respiratory Infectious Disease Risk
- Identification of adventitious lung sounds in children with respiratory illnesses in Bangladesh using artificial intelligence and digital auscultation
- Development and Internal Validation of a Prediction Model Incorporating Respiratory Muscle Function for CAT Score Deterioration in Stable COPD
- Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections
BibTeX
@article{li2026novel,
title = {{A novel multiplex assay for species-level identification of non-tuberculous mycobacteria in culture-positive respiratory specimens based on capillary electrophoresis: development and clinical validation}},
author = {Zhen Li and Yaocheng Wang and Li Lai and Yi Huang and Li Li},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.1966137},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1966137/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A novel multiplex assay for species-level identification of non-tuberculous mycobacteria in culture-positive respiratory specimens based on capillary electrophoresis: development and clinical validation
AU - Zhen Li
AU - Yaocheng Wang
AU - Li Lai
AU - Yi Huang
AU - Li Li
PY - 2026
DA - 2026/10/08
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1966137
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1966137/full
AB - Nontuberculous mycobacterial pulmonary disease (NTM-PD) is rising globally, driven predominantly by Mycobacterium avium complex (MAC), yet treatment is highly species-dependent. We developed a Multiplex assay targeting four clinically important non-tuberculous mycobacteria (NTM) species– M. avium , M. intracellulare , M. abscessus , and M. fortuitum –and compared it with metagenomic next-generation sequencing (mNGS), using colony-based multigene Sanger sequencing as the reference method. Among 101 specimens, 63 (62.4%) yielded polymicrobial results, of which mixed-species detection of M. avium – M. intracellulare accounted for 46 (73.0%). The Multiplex assay and mNGS showed no statistically significant difference in overall accuracy in this cohort (82.2% vs. 81.2%; raw agreement 83.2%, P = 1.000). The Multiplex assay achieved 100.0% sensitivity for all four species, with specificity of 87.8% and 87.5% for M. avium and M. intracellulare , respectively, and >98% for M. abscessus and M. fortuitum ; mNGS showed the converse pattern, with lower MAC sensitivity (88.5%, 92.2%) but higher MAC specificity (93.9%, 95.8%). Requiring only a single PCR reaction without sequencing or bioinformatic analysis, the Multiplex assay showed no statistically significant difference in diagnostic accuracy from mNGS in this culture-positive cohort, without requiring library preparation or sequencing, representing a promising candidate for further evaluation as a routine NTM species-identification tool.
SN - 1664-302X
ER -